Industrial separation specialist Upfront Chromatography believes
that its new range of disposable absorption chromatography units
will help monoclonal antibody (MAb) makers significantly reduce
production costs.
Sigma-Aldrich has introduced a new high-throughput (HT) plasmid DNA
purification kit for transfection applications in pharmaceutical
and biotechnology research.
US researchers have developed a more sensitive method of detecting
whether athletes have taken drugs to artificially boost
testosterone which increases physical performance.
Outsourcing-Pharma.com presents its latest round-up of news in the
contract development and manufacturing sector, with updates from
Rentschler Biotechnologie, Eden Biodesign, Emcure Pharmaceuticals
and new start-up Appian Labs.
Visiongain's third annual conference on Pharmaceutical
Anti-counterfeiting Strategies kicks off next week, covering many
aspects of the problem from technological deterrents, regulatory
developments in the EU and US and the implications...
A recent study conducted by Eli Lilly's research laboratories
division suggests that quantitative ion mobility spectrometry
(qIMS) can offer drugmakers a rapid on-site means of verifying the
cleanliness of manufacturing equipment.
Slovenian drugmaker Krka has paid just under $1.6m (€1m) for 7.5
per cent stakes in two Chinese drug and chemicals firms, namely
Zhejiang Menovo Pharmaceuticals and Anhui Menovo Pharmaceuticals.
European pharmaceutical manufacturers stepped up calls for a
blanket ban on repackaging of pharmaceuticals last week, suggesting
that this would be the single most effective way to seal the supply
chain for counterfeiting drugs.
US technology specialist Honeywell International says that new
features of its POMSnet manufacturing execution system (MES) can
help pharmaceutical firms reduce production errors.
Outsourcing-Pharma.com presents a round-up of recent contracts
signed in the manufacturing arena, featuring new deals for Angel
Biotechnology, PharmEng and Akela Pharma.
DSM and the European Chemical Industry Council (CEFIC) have
criticised the European Commission's proposals for tackling
counterfeit active pharmaceutical ingredients (APIs).
A US senator has asked the Food and Drug Administration (FDA) for a
probe into outsourcing of production for pharmaceuticals, as well
as ways to make drugmakers accountable for products which fail to
meet quality standards.
Beckman Coulter and Orchid Cellmark have filed a lawsuit against
Sequenom in another patent infringement case that alleges Sequenom
is guilty of violating patents belonging to Orchid and licensed to
Beckman.
GE Healthcare has announced its intention to invest $20m in radical
new technology, which will allow laboratory research results to be
transmitted and shared amongst doctors worldwide setting to define
a new age in patient care.
In the latest biotechnology courtroom battle, Oxford Gene
Technology (OGT) reported that it has filed suit against BioArray
Solutions for deliberately infringing three of its patents that
relates to technology capable of detailed...
Patheon gave an update on its restructuring plans in Puerto Rico
yesterday, saying that its plant in Manati will be updated to
provide contract manufacturing of high-potency drugs and controlled
substances.
Introgen Therapeutics says advances in its biologics manufacturing
and storage technologies have allowed it to broaden the scope of
its contract manufacturing operations and set up a new unit called
Introgen Technical Services (ITS).
Japanese glass and chemical company Central Glass has found a swift
route into the contract manufacturing market for active
pharmaceutical ingredients (APIs) in Europe via the purchase of
Girindus' facility in Halle-Kuensebeck.
The pharmaceutical industry could save millions by adopting new
crystal monitoring technology, according to research published in
Crystal Growth and Design.
Sartorius Stedim Biotech has teamed up with Wuxi AppTec to help
companies remove some of the strain of carrying out viral clearance
testing, which for large biopharmaceutical companies can carry a
price tag of up to $1m a year.
Life Science equipment specialists Thermo Fisher Scientific has
launched its latest liquid chromatography-mass spectrometry (LC-MS)
system, which builds on existing mass analyser technology to
produce a instrument for scientists in...
The American Society for Mass Spectrometry meeting (ASMS) was the
scene of a lot of activity from Agilent this week as the lab
instrument specialist unleashed new mass spectrometer products at
the show.
Contract manufacturing group Helix Medical hopes that expansion of
its global production capacity will help it corner the
pharmaceutical industry's injection moulding thermoplastics market.
West Analytical Services says it has introduced a testing platform
to help customers testing pulmonary and nasal drug products and
their delivery devices.
The new European Chemicals Agency (ECHA) opened its doors in
Helsinki this week, with questions raised immediately about its
ability to handle the thousands of registration requests required
under the controversial REACH legislation.
US drug giant Pfizer hopes that its collaboration with student
engineers at New Jersey's Rowan University will help lessen the
environmental impact of its best selling arthritis drug Celebrex
(celeboxib).
Agilent Technologies has licensed BIA Separations' bio-monolithic
technology and intends to use it in the commercialisation of
analytical high performance liquid chromatography (HPLC)
bio-monolith columns.
Canadian contract manufacturer and consultancy firm PharmEng
International has published its 2007 accounts, and says it remains
firmly focused on getting into the black in 2008.
The Bio Affinity Company (BAC) has been contracted to create a
purification method for the production of a recombinant protein,
the clotting agent factor VIIa, made in the milk of transgenic
animals.
China's Wuxi PharmaTech saw revenues race away across its divisions
in the first quarter of 2008, benefitting from the continued shift
towards outsourcing of manufacturing and laboratory functions by
the pharmaceutical industry.
A comprehensive review of stimuli-responsive molecularly imprinted
polymers (MIPs) in Current Drug Delivery has highlighted
their potential within the pharmaceutical industry.
The world's first high-powered benchtop wavelength dispersive XRF
spectrometer has been introduced as high-precision analysis at low
concentration levels is now available to laboratories and research
institutions.
Canada has bought its laboratory legislation in line with other
international standards as the country proposes new legislation
designed to tighten safety and access to human pathogens and
toxins.
Microscopy giants Olympus have added a confocal laser scanning
microscope to its ever expanding range packing this latest model
with a 1310 nm laser that can image components encased within a
silicon shell.
A 20ft container of counterfeit pharmaceuticals has been impounded
by the Nigerian National Agency for Food and Drug Administration
and Control (NAFDAC).
Irish drugmaker Elan is considering a separate stock exchange
listing for its contract services unit, Elan Drug Technology,
according to comments by executives at its recent annual general
meeting.
Pharmaceutical manufacturers are now withdrawing from manufacturing
at an unprecedented rate, with four of the top 10 players
announcing major new outsourcing programmes in 2007, says IMS in a
new document which explores the implications...
Catalent Pharma Solutions has reported a profit drop in its latest
financial results, completed the sale of one of its businesses, and
is undergoing regulatory scrutiny over the overall control and
management of quality systems at...
Cell culture analysis specialists, Innovatis makes available a new
range of bench-top systems that boasts a standardised cell counting
and analysis of the quality of cell culture samples in as little as
10 seconds.
Germany's Rentschler Biotechnologie and Boehringer Ingelheim have
inked a preferred partnership agreement to jointly offer customers
a more streamlined biopharmaceutical production option.
Europe is tipped to witness the most significant worldwide gains in
biopharmaceutical manufacturing production capacity in the coming
years, despite an overall global decline in capacity utilisation by
the industry.
The FDA has issued US drug maker Scientific Laboratories with an
injunction preventing it from producing drugs until
manufacturing operations are brought up to code.
